Nkarta Inc (NKTX)
6.73
+0.20
(+3.06%)
USD |
NASDAQ |
May 20, 16:00
6.73
0.00 (0.00%)
Pre-Market: 09:25
Nkarta Price to Book Value: 1.001 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 1.001 |
| May 17, 2024 | 0.9715 |
| May 16, 2024 | 1.015 |
| May 15, 2024 | 1.024 |
| May 14, 2024 | 0.9745 |
| May 13, 2024 | 0.9789 |
| May 10, 2024 | 0.9298 |
| May 09, 2024 | 0.9373 |
| May 08, 2024 | 0.9522 |
| May 07, 2024 | 1.012 |
| May 06, 2024 | 1.056 |
| May 03, 2024 | 1.101 |
| May 02, 2024 | 1.120 |
| May 01, 2024 | 1.114 |
| April 30, 2024 | 0.9938 |
| April 29, 2024 | 1.030 |
| April 26, 2024 | 1.022 |
| April 25, 2024 | 1.015 |
| April 24, 2024 | 1.067 |
| April 23, 2024 | 1.125 |
| April 22, 2024 | 1.100 |
| April 19, 2024 | 1.085 |
| April 18, 2024 | 1.159 |
| April 17, 2024 | 1.169 |
| April 16, 2024 | 1.159 |
| Date | Value |
|---|---|
| April 15, 2024 | 1.299 |
| April 12, 2024 | 1.30 |
| April 11, 2024 | 1.309 |
| April 10, 2024 | 1.199 |
| April 09, 2024 | 1.302 |
| April 08, 2024 | 1.318 |
| April 05, 2024 | 1.397 |
| April 04, 2024 | 1.398 |
| April 03, 2024 | 1.411 |
| April 02, 2024 | 1.471 |
| April 01, 2024 | 1.609 |
| March 28, 2024 | 2.786 |
| March 27, 2024 | 2.857 |
| March 26, 2024 | 1.785 |
| March 25, 2024 | 1.897 |
| March 22, 2024 | 1.613 |
| March 21, 2024 | 2.347 |
| March 20, 2024 | 2.313 |
| March 19, 2024 | 2.210 |
| March 18, 2024 | 2.061 |
| March 15, 2024 | 2.189 |
| March 14, 2024 | 2.048 |
| March 13, 2024 | 2.322 |
| March 12, 2024 | 2.358 |
| March 11, 2024 | 2.520 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2145
Minimum
Sep 29 2023
7.358
Maximum
Dec 23 2020
1.996
Average
1.632
Median
Jul 15 2022
Price to Book Value Benchmarks
| Cutera Inc | -- |
| GT Biopharma Inc | 2.028 |
| Outlook Therapeutics Inc | -- |
| IMAC Holdings Inc | -- |
| Capricor Therapeutics Inc | 10.87 |
Price to Book Value Related Metrics
| Price | 6.73 |
| Earnings Yield | -34.92% |
| Market Cap | 474.25M |